Literature DB >> 8485712

Phosphorylation of elongation factor 2 in normal and malignant rat glial cells.

D M Bagaglio1, E H Cheng, F S Gorelick, K Mitsui, A C Nairn, W N Hait.   

Abstract

Certain calmodulin (CaM)-dependent protein kinases phosphorylate substrates have been implicated in regulating cellular proliferation. In this study, CaM-dependent phosphorylation has been examined in normal and tumor tissue from rat brain to determine whether differences exist. Using in vitro phosphorylation reactions, we compared endogenous substrates for Ca2+/CaM-dependent protein kinases in rat brain white matter (RBWM), a tissue rich in normal glia, to those of C6 rat glioma cells. A major phosphoprotein having a M(r) of 100,000 was observed in proliferating C6 cells that was not present in RBWM or in nonproliferating cells. Phosphorylation was stimulated by Ca2+ and CaM and inhibited by trifluoperazine. An antibody to elongation factor 2 (EF-2) immunoprecipitated the M(r) 100,000 protein from C6 cells. EF-2 was present in RBWM but was not phosphorylated. Homogenates of RBWM did not phosphorylate exogenous EF-2, which suggested the absence of CaM kinase III activity in normal glial tissue. Furthermore, the addition of purified, exogenous CaM kinase III to homogenates of RBWM resulted in EF-2 phosphorylation. These data demonstrate that a basal level of EF-2 phosphorylation exists in proliferating glioma cells that is markedly diminished or absent in normal glial tissue and is due to the activity of CaM kinase III.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485712

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.

Authors:  Flore Kruiswijk; Laurensia Yuniati; Roberto Magliozzi; Teck Yew Low; Ratna Lim; Renske Bolder; Shabaz Mohammed; Christopher G Proud; Albert J R Heck; Michele Pagano; Daniele Guardavaccaro
Journal:  Sci Signal       Date:  2012-06-05       Impact factor: 8.192

2.  Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells.

Authors:  Li Zhang; Yi Zhang; Xiao-yuan Liu; Zheng-hong Qin; Jin-ming Yang
Journal:  Acta Pharmacol Sin       Date:  2011-01-31       Impact factor: 6.150

3.  Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase.

Authors:  A G Ryazanov; M D Ward; C E Mendola; K S Pavur; M V Dorovkov; M Wiedmann; H Erdjument-Bromage; P Tempst; T G Parmer; C R Prostko; F J Germino; W N Hait
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions.

Authors:  Kathryn J Huber-Keener; Brad R Evans; Xingcong Ren; Yan Cheng; Yi Zhang; William N Hait; Jin-Ming Yang
Journal:  Biochem Biophys Res Commun       Date:  2012-06-27       Impact factor: 3.575

Review 5.  Cellular ADP-ribosylation of elongation factor 2.

Authors:  W J Iglewski
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

6.  eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.

Authors:  Y Cheng; X Ren; Y Yuan; Y Shan; L Li; X Chen; L Zhang; Y Takahashi; J W Yang; B Han; J Liao; Y Li; H Harvey; A Ryazanov; G P Robertson; G Wan; D Liu; A F Chen; Y Tao; J-M Yang
Journal:  Oncogene       Date:  2016-05-16       Impact factor: 9.867

7.  Afferent regulation of chicken auditory brainstem neurons: rapid changes in phosphorylation of elongation factor 2.

Authors:  Ethan G McBride; Edwin W Rubel; Yuan Wang
Journal:  J Comp Neurol       Date:  2013-04-01       Impact factor: 3.215

8.  The molecular mechanism of eukaryotic elongation factor 2 kinase activation.

Authors:  Clint D J Tavares; Scarlett B Ferguson; David H Giles; Qiantao Wang; Rebecca M Wellmann; John P O'Brien; Mangalika Warthaka; Jennifer S Brodbelt; Pengyu Ren; Kevin N Dalby
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

9.  Eukaryotic elongation factor 2 kinase regulates the development of hypertension through oxidative stress-dependent vascular inflammation.

Authors:  Tatsuya Usui; Muneyoshi Okada; Yukio Hara; Hideyuki Yamawaki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-28       Impact factor: 4.733

10.  Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy.

Authors:  Hao Wu; Hua Zhu; David X Liu; Ting-Kuang Niu; Xingcong Ren; Rajesh Patel; William N Hait; Jin-Ming Yang
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.